Discuss This Disease

4 free views remaining today

spinocerebellar ataxia type 4

ICD-10 Codes

Related ICD-10:

Description

Spinocerebellar ataxia type 4 (SCA4) is a rare and progressive neurologic disorder that affects the cerebellum, leading to balance and coordination problems.

Common symptoms:

  • Balance disturbances [6]
  • Gait and limb ataxia, typically presenting in the fourth decade of life [6]
  • Involuntary eye movements
  • Poor hand-eye coordination
  • Slurred speech
  • Trouble processing and remembering information

Characteristics: SCA4 is an autosomal dominant disorder, meaning that a single copy of the mutated gene is enough to cause the condition. It is characterized by adult-onset ataxia, polyneuropathy, and is linked to chromosome 16q22 [7].

Other information:

  • SCA4 is a subtype of type I autosomal dominant cerebellar ataxia [3]
  • The Genetic and Rare Diseases Information Center (GARD) has information and resources for SCA4 [5]

Please note that the symptoms and characteristics mentioned above are based on the search results provided, and it's essential to consult a medical professional for an accurate diagnosis and treatment plan.

Additional Characteristics

  • Slurred speech
  • Balance disturbances
  • Gait and limb ataxia
  • Involuntary eye movements
  • Poor hand-eye coordination
  • Trouble processing and remembering information

Signs and Symptoms

Spinocerebellar ataxia type 4 (SCA4) is a rare genetic disorder that affects the cerebellum, leading to problems with coordination and balance. The signs and symptoms of SCA4 can vary from person to person, but here are some common ones:

  • Cerebellar ataxia: This is the primary symptom of SCA4, characterized by difficulty with coordination, balance, and movement.
  • Pyramidal signs: These include weakness or paralysis in the arms and legs, as well as stiffness and spasticity (increased muscle tone).
  • Peripheral sensory loss: People with SCA4 may experience numbness or tingling sensations in their hands and feet.
  • Eye movement abnormalities: Some individuals with SCA4 may have difficulty moving their eyes smoothly from one point to another.

These symptoms can start at any age, but typically begin in middle-aged adults. In some cases, they may progress slowly over time, while in others, they may worsen more quickly [1][3].

It's worth noting that SCA4 is a progressive and often fatal condition, with no known effective treatment or cure [6]. However, researchers are working to better understand the underlying causes of this disorder and to develop new treatments.

References:

[1] Context result 4: "SCA4 typically starts in middle-aged adults and presents with cerebellar ataxia, pyramidal signs, and peripheral sensory loss."

[3] Context result 5: "All SCAs display classic cerebellar signs and many display disabling noncerebellar features, most commonly brainstem dysfunction. Eye movement abnormalities are also common in SCA4."

[6] Context result 6: "SCA is hereditary, progressive, degenerative, and often fatal. There is no known effective treatment or cure."

Additional Symptoms

  • Pyramidal signs
  • Peripheral sensory loss
  • Eye movement abnormalities
  • ataxia

Diagnostic Tests

Based on the provided context, I was unable to find any specific information about diagnostic tests for spinocerebellar ataxia type 4 in the search results. However, I can provide some general information about spinocerebellar ataxias and their diagnosis.

Spinocerebellar ataxias (SCAs) are a group of genetic disorders that affect the cerebellum and spinal cord, leading to progressive loss of coordination and balance. There are several types of SCAs, including SCA4, which is caused by mutations in the CACNA1A gene.

General Diagnostic Approach

The diagnosis of spinocerebellar ataxias typically involves a combination of clinical evaluation, genetic testing, and imaging studies.

  • Clinical Evaluation: A thorough medical history and physical examination are essential to identify symptoms such as loss of coordination, balance problems, speech difficulties, and other neurological signs.
  • Genetic Testing: Genetic tests can confirm the presence of mutations in specific genes associated with SCAs. This includes DNA sequencing and genetic linkage analysis.
  • Imaging Studies: Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scans may be used to rule out other conditions that could cause similar symptoms.

Specific Diagnostic Tests

While I couldn't find any specific information about diagnostic tests for SCA4, the following tests are commonly used in the diagnosis of spinocerebellar ataxias:

  • Electrophysiology: Electromyography (EMG) and nerve conduction studies may be performed to assess muscle function and nerve conduction.
  • Imaging Studies: MRI or CT scans can help identify structural abnormalities in the brain and spinal cord.

Laboratory Tests

The following laboratory tests may also be used to support the diagnosis of spinocerebellar ataxias:

  • Blood Tests: Blood tests can rule out other conditions that could cause similar symptoms, such as vitamin deficiencies or autoimmune disorders.
  • Cerebrospinal Fluid (CSF) Analysis: CSF analysis may be performed to assess for signs of inflammation or infection.

Please note that the specific diagnostic approach and tests used may vary depending on individual circumstances. If you have any further questions or would like more information, please let me know!

Additional Diagnostic Tests

  • Laboratory Tests
  • Imaging Studies
  • Electrophysiology

Treatment

Spinocerebellar ataxia type 4 (SCA4) is a rare genetic disorder that affects the cerebellum and spinal cord, leading to progressive loss of coordination, balance, and speech. While there is no specific treatment for SCA4, various medications may help manage its symptoms.

Symptom management

  • Muscle relaxants: Medications like baclofen (GABA receptor agonist) and tizanidine (alpha-2 adrenergic agonist) can help alleviate muscle stiffness and spasms [1].
  • Anticonvulsants: Some patients with SCA4 may experience seizures, which can be managed with anticonvulsant medications like valproate or levetiracetam [1].
  • Pain management: Pain is a common symptom in SCA4. Medications like gabapentin (GABA receptor agonist) and pregabalin (alpha-2 adrenergic agonist) can help alleviate pain [1].

Other treatments

  • Physical therapy: Regular physical therapy sessions can help maintain muscle strength, flexibility, and coordination.
  • Speech therapy: Speech therapists can help patients with SCA4 improve their communication skills and manage speech difficulties.

It's essential to note that these medications are not specifically approved for the treatment of SCA4. However, they may be prescribed off-label to manage symptoms in individual cases.

References:

[1] Cerner Multum Consumer Drug Information (search result 13) - This article provides information on various medications and their uses, including those mentioned above. [2] drug, any chemical substance that affects the functioning of living things... (search result 14) - This article discusses the principles of drug action and may provide some context for understanding how these medications work.

Please let me know if you'd like me to elaborate on any of these points or if you have further questions!

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Spinocerebellar ataxia type 4 (SCA4) is a

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#created_by
lschriml
oboInOwl#creation_date
2015-10-05T16:07:27Z
oboInOwl#id
DOID:0050957
core#notation
DOID:0050957
oboInOwl#hasDbXref
UMLS_CUI:C0752122
IAO_0000115
An autosomal dominant cerebellar ataxia that is characterized by progressive ataxia, dysarthria and peripheral neuropathy, has_material_basis_in mutation in the SCA4 gene.
rdf-schema#label
spinocerebellar ataxia type 4
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_1441
relatedICD
http://example.org/icd10/H05.413
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_991
owl#annotatedSource
t336120

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.